Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kehang Liu"'
Autor:
Huidan Zhang, Junai Zhen, Rong Zhang, Yangke Wanyan, Kehang Liu, Xueli Yuan, Liping Tao, Yuqing Chen
Publikováno v:
Cell Death Discovery, Vol 8, Iss 1, Pp 1-13 (2022)
Abstract Cathelicidin hCAP18/LL-37 can resist infection from various pathogens and is an essential component of the human immune system. Accumulating evidence has indicated that hCAP18/LL-37 plays a tissue-specific role in human cancer. However, its
Externí odkaz:
https://doaj.org/article/93a916a378874be3bf75cc60500b9d82
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1130 (2023)
The humoral immune response and safety of the fourth dose of the coronavirus disease 2019 (COVID-19) vaccine in solid organ transplant (SOT) recipients need to be fully elucidated. We conducted a systematic review and meta-analysis to assess the effi
Externí odkaz:
https://doaj.org/article/3ad5470e5e7c4c50a7b1d0dc6ee708d3
Publikováno v:
ACS Omega, Vol 5, Iss 34, Pp 21513-21523 (2020)
Externí odkaz:
https://doaj.org/article/4472df01d6d244deaa0ea4374cb827fb
Autor:
Caiyun Li, Hongyan Liu, Yunqing Yang, Xixi Xu, Tongtong Lv, Huidan Zhang, Kehang Liu, Shuangquan Zhang, Yuqing Chen
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Development of antimicrobial peptides (AMPs) as highly effective and selective anticancer agents would represent great progress in cancer treatment. Here we show that myristoyl-CM4, a new synthetic analog generated by N-myristoylation of AMPs CM4, ha
Externí odkaz:
https://doaj.org/article/55776eef4d00482e827879940e3933e4
Autor:
Yangke Wanyan, Xixi Xu, Kehang Liu, Huidan Zhang, Junai Zhen, Rong Zhang, Jumei Wen, Ping Liu, Yuqing Chen
Publikováno v:
Molecules, Vol 25, Iss 23, p 5778 (2020)
Inhibition of the glycolytic pathway is a critical strategy in anticancer therapy because of the role of aerobic glycolysis in cancer cells. The glycolytic inhibitor 2-Deoxy-d-glucose (2-DG) has shown potential in combination with other anticancer ag
Externí odkaz:
https://doaj.org/article/63c1be6310894c3d9113d88e3aad8b1e
Publikováno v:
ACS Omega
ACS Omega, Vol 5, Iss 34, Pp 21513-21523 (2020)
ACS Omega, Vol 5, Iss 34, Pp 21513-21523 (2020)
Antimicrobial peptides (AMPs) are important anticancer resources, and exploring AMP conjugates as highly effective and selective anticancer agents would represent new progress in cancer treatment. In this study, we synthesized C4–C16 fatty-acyl-con
Autor:
Huidan, Zhang, Junai, Zhen, Rong, Zhang, Yangke, Wanyan, Kehang, Liu, Xueli, Yuan, Liping, Tao, Yuqing, Chen
Publikováno v:
Cell Death Discovery
Cathelicidin hCAP18/LL-37 can resist infection from various pathogens and is an essential component of the human immune system. Accumulating evidence has indicated that hCAP18/LL-37 plays a tissue-specific role in human cancer. However, its function
Publikováno v:
Drug Design, Development and Therapy. 13:2153-2167
Purpose: There is an urgent need for the development of novel, effective, and less toxic drugs to treat leukemia. Antimicrobial peptides (AMPs) have received much more attention as alternative chemotherapeutic agents. This study aimed to examined the
Autor:
Junai Zhen, Jumei Wen, Kehang Liu, Rong Zhang, Yangke Wanyan, Yuqing Chen, Ping Liu, Huidan Zhang, Xixi Xu
Publikováno v:
Molecules
Volume 25
Issue 23
Molecules, Vol 25, Iss 5778, p 5778 (2020)
Volume 25
Issue 23
Molecules, Vol 25, Iss 5778, p 5778 (2020)
Inhibition of the glycolytic pathway is a critical strategy in anticancer therapy because of the role of aerobic glycolysis in cancer cells. The glycolytic inhibitor 2-Deoxy-d-glucose (2-DG) has shown potential in combination with other anticancer ag
Autor:
Tongtong Lv, Shuangquan Zhang, Huidan Zhang, Caiyun Li, Yuqing Chen, Xixi Xu, Hongyan Liu, Yunqing Yang, Kehang Liu
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 9 (2018)
Frontiers in Pharmacology, Vol 9 (2018)
Development of antimicrobial peptides (AMPs) as highly effective and selective anticancer agents would represent great progress in cancer treatment. Here we show that myristoyl-CM4, a new synthetic analog generated by N-myristoylation of antimicrobia